Literature DB >> 26159296

PI3K/Akt in platelet integrin signaling and implications in thrombosis.

Gianni F Guidetti1, Ilaria Canobbio1, Mauro Torti2.   

Abstract

Blood platelets are anucleated circulating cells that play a critical role in hemostasis and are also implicated in arterial thrombosis, a major cause of death worldwide. The biological function of platelets strongly relies in their reactiveness to a variety of extracellular agonists that regulate their adhesion to extracellular matrix at the site of vascular injury and their ability to form rapidly growing cell aggregates. Among the membrane receptors expressed on the cell surface, integrins are crucial for both platelet activation, adhesion and aggregation. Integrin affinity for specific ligands is regulated by intracellular signaling pathways activated in stimulated platelets, and, once engaged, integrins themselves generate and propagate signals inside the cells to reinforce and consolidate platelet response and thrombus formation. Phosphatidylinositol 3-Kinases (PI3Ks) have emerged as crucial players in platelet activation, and they are directly implicated in the regulation of integrin function. This review will discuss the contribution of PI3Ks in platelet integrin signaling, focusing on the role of specific members of class I PI3Ks and their downstream effector Akt on both integrin inside-out and outside-in signaling. The contribution of the PI3K/Akt pathways stimulated by integrin engagement and platelet activation in thrombus formation and stabilization will also be discussed in order to highlight the possibility to target these enzymes in effective anti-thrombotic therapeutic strategies.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adhesion; Aggregation; Integrins; Platelets; Thrombus formation

Mesh:

Substances:

Year:  2015        PMID: 26159296     DOI: 10.1016/j.jbior.2015.06.001

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  41 in total

Review 1.  The extracellular matrix as a key regulator of intracellular signalling networks.

Authors:  Jordan F Hastings; Joanna N Skhinas; Dirk Fey; David R Croucher; Thomas R Cox
Journal:  Br J Pharmacol       Date:  2018-04-19       Impact factor: 8.739

2.  JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation.

Authors:  Bärbel Edelmann; Nibedita Gupta; Tina M Schnoeder; Anja M Oelschlegel; Khurrum Shahzad; Jürgen Goldschmidt; Lars Philipsen; Soenke Weinert; Aniket Ghosh; Felix C Saalfeld; Subbaiah Chary Nimmagadda; Peter Müller; Rüdiger Braun-Dullaeus; Juliane Mohr; Denise Wolleschak; Stefanie Kliche; Holger Amthauer; Florian H Heidel; Burkhart Schraven; Berend Isermann; Andreas J Müller; Thomas Fischer
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

3.  DREAM plays an important role in platelet activation and thrombogenesis.

Authors:  Kyungho Kim; Alan Tseng; Andrew Barazia; Joseph E Italiano; Jaehyung Cho
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

Review 4.  Integrin αIIbβ3 outside-in signaling.

Authors:  Tom N Durrant; Marion T van den Bosch; Ingeborg Hers
Journal:  Blood       Date:  2017-08-09       Impact factor: 22.113

5.  In-depth PtdIns(3,4,5)P3 signalosome analysis identifies DAPP1 as a negative regulator of GPVI-driven platelet function.

Authors:  Tom N Durrant; James L Hutchinson; Kate J Heesom; Karen E Anderson; Len R Stephens; Phillip T Hawkins; Aaron J Marshall; Samantha F Moore; Ingeborg Hers
Journal:  Blood Adv       Date:  2017-06-13

Review 6.  Platelets in neutrophil recruitment to sites of inflammation.

Authors:  Simon Pitchford; Dingxin Pan; Heidi C E Welch
Journal:  Curr Opin Hematol       Date:  2017-01       Impact factor: 3.284

Review 7.  Platelet signaling: a complex interplay between inhibitory and activatory networks.

Authors:  A P Bye; A J Unsworth; J M Gibbins
Journal:  J Thromb Haemost       Date:  2016-04-09       Impact factor: 5.824

8.  The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells.

Authors:  Christina Cho; Carol Horzempa; David Jones; Paula J McKeown-Longo
Journal:  BMC Cancer       Date:  2016-08-02       Impact factor: 4.430

9.  Voltage-Gated K+ Channel, Kv3.3 Is Involved in Hemin-Induced K562 Differentiation.

Authors:  Min Seok Song; Seon Young Choi; Pan Dong Ryu; So Yeong Lee
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

10.  Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression.

Authors:  Linda S Steelman; Steve L Abrams; Peter Ruvolo; Vivian Ruvolo; Lucio Cocco; Stefano Ratti; Alberto M Martelli; Luca M Neri; Saverio Candido; Massimo Libra; James A McCubrey
Journal:  Oncotarget       Date:  2017-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.